China's Alwin Capital closes new dual-currency fund at $281m to invest in life sciences

China's Alwin Capital closes new dual-currency fund at $281m to invest in life sciences

Photo by Sangharsh Lohakare on Unsplash

04 October, 2022

Alwin Capital biotech gene-editing life sciences

Printed by Unregistered user on Tue, 16 Dec 2025 18:06:35 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China's 'overinvested' healthcare sector ripe for consolidation post COVID: Qiming

Venture Capital

HK-based life sciences VC Delos Capital holds first close of Fund III at $300m

Read more from Greater China

Chinese AI chip firm Biren eyes Hong Kong IPO in coming weeks

Policy & Regulations

Beijing bourse weighs overhaul of IPO subscription rules as idle capital surges